Oracea
Oracea Official FDA information, side effects and uses.
CollaGenex Pharmaceuticals to Present at the Thomas Weisel Partners Healthcare Conference 2007 on September 6th (Business Wire via Yahoo! Finance)
Posted by Oracea (Oracea) on Sun, 09 Sep 2007 23:16:05 +0000
Posted by Oracea (Oracea) on Sun, 09 Sep 2007 23:16:05 +0000
NEWTOWN, Pa.----CollaGenex Pharmaceuticals, Inc. today announced that Nancy C. Broadbent, chief financial officer, will present at the Thomas Weisel Partners Healthcare Conference 2007.
CollaGenex Pharmaceuticals Announces Highly Positive Results of Phase 2 Dose-Finding Trial of Col-118 for the Treatment ... (Business Wire via Yahoo! Finance)
NEWTOWN, Pa.----CollaGenex Pharmaceuticals, Inc. today announced results of a Phase 2 dose-finding study designed to evaluate the safety and efficacy of Col-118 for the treatment of erythema.
